Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stuart Holden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Schoenberg - $4.48M in URGN purchases and sales in the last 12 months
- Jason Drew Smith - $212K in URGN purchases and sales in the last 12 months
- Chris Degnan - $81K in URGN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stuart Holden?
Stuart Holden is a corporate insider, tracked as Director of UroGen Pharma Ltd. (URGN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Stuart Holden last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 3 filings going back to 2025.
